Updated Centers for Disease Control and Prevention Guidelines on Opioid Prescribing: What Should Surgeons Know?
John D CramerSamantha AnneMichael J BrennerPublished in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)
The Centers for Disease Control and Prevention (CDC) recently published a 2022 guideline on opioid prescribing for acute, subacute, and chronic pain. This information is relevant to surgeons because many patients receive their first opioid prescription after surgery. When prescribing opioids, surgeons walk the line between benefit and harm. Many of the CDC recommendations mirror the AAO-HNS Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations. For example, opioids are not recommended as first-line therapy for acute pain from otolaryngology-head, and neck surgery procedures. New insights include safeguards and strategies to mitigate the risk of complications in patients with chronic pain undergoing surgical procedures. Consultation with a pain specialist should be considered for patients transitioning from acute to chronic pain, cognizant of the risks of abrupt discontinuation of opioids in patients with opioid use disorder. This article summarizes key considerations for providing individualized, evidence-based perioperative pain management.
Keyphrases
- chronic pain
- pain management
- primary care
- liver failure
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- palliative care
- healthcare
- quality improvement
- respiratory failure
- prognostic factors
- minimally invasive
- systematic review
- emergency department
- intensive care unit
- clinical practice
- spinal cord injury
- cardiac surgery
- randomized controlled trial
- risk factors
- adverse drug
- thoracic surgery
- spinal cord
- acute kidney injury
- neuropathic pain
- patient reported
- acute respiratory distress syndrome